Rating Change
JP Morgan reiterated its Neutral rating on LifeStance Health Group, Inc. (NASDAQ:LFST) on August 14, 2026.
reiterateNASDAQ:LFST
JP Morgan Reiterates Neutral Rating on LifeStance Health Group, Inc. (LFST)
JP Morgan reiterated its Neutral rating on LifeStance Health Group, Inc. (NASDAQ:LFST) on August 14, 2026.
At publication ·
What changed
LifeStance Health Group, Inc. (NASDAQ:LFST) · reiterate
- Firm
- JP Morgan
- Rating
- Neutral to Neutral
- Price at event
- $12.42
- Market capitalization
- $2.6B
At a glance
Key takeaways
- JP Morgan reiterated a Neutral rating on LifeStance Health Group (LFST) on August 14, 2026, while the stock trades at $12.42 with a $2.6B market capitalization.
Market Context
LifeStance Health Group, Inc. operates in the Healthcare sector. The stock currently trades at $12.42 with a market capitalization of $2.6B. The stock has gained 132.2% over the past 52 weeks.
Analyst coverage from JP Morgan provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for LifeStance Health Group, Inc.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for LifeStance Health Group, Inc.
Among the 10 most recent ratings: 7 Buy, 3 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Aug 14, 2026 | JP Morgan | Neutral | N/A |
| Aug 07, 2026 | BTIG | Buy | N/A |
| Jul 24, 2026 | BTIG | Buy | N/A |
| Jul 21, 2026 | Canaccord Genuity | Buy | N/A |
| Jul 14, 2026 | Barclays | Overweight | N/A |
Related Tools: Analyst Ratings Dashboard | View LFST Stock Page
Frequently Asked Questions
What does the Neutral rating mean for LFST?
A rating of Neutral from JP Morgan reflects the analyst's outlook on LifeStance Health Group, Inc. (NASDAQ:LFST). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the LFST forecast page.